K. Lauritsen
- Surgery top 0.5%
- Gastroenterology top 0.05%
- Genetics top 2%
- Epidemiology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- J Rask-MadsenKlaus BukhaveNicholas J. TalleyL. LaursenLaurits S. LaursenTroels HavelundOla JunghardTore Lind
- Topics
- Helicobacter pylori-related gastroenterology studies (59 papers)Gastroesophageal reflux and treatments (40 papers)Eosinophilic Esophagitis (26 papers)
- Cited by
- GastroenterologySurgeryGenetics
- Journals
- New England Journal of MedicineThe LancetSHILAP Revista de lepidopterología
In The Last Decade
K. Lauritsen
102 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Surgery 3.7k
- Gastroenterology 3.0k
- Genetics 1.1k
- Epidemiology 816
- Pulmonary and Respiratory Medicine 481
Countries citing papers authored by K. Lauritsen
This map shows the geographic impact of K. Lauritsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Lauritsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Lauritsen more than expected).
Fields of papers citing papers by K. Lauritsen
This network shows the impact of papers produced by K. Lauritsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Lauritsen. The network helps show where K. Lauritsen may publish in the future.
Co-authorship network of co-authors of K. Lauritsen
This figure shows the co-authorship network connecting the top 25 collaborators of K. Lauritsen. A scholar is included among the top collaborators of K. Lauritsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Lauritsen. K. Lauritsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Effects of natalizumab on gut healing in a phase 3 study of active Crohn's disease therapy (ENACT-1) | 9 |
| 2 | Natalizumab decreases inflammatory cells within the colonic lamina propria of patients with active Crohn's disease: results from ENACT-1 | 3 |
| 3 | 60 | |
| 4 | 70 | |
| 5 | 126 | |
| 6 | 227 | |
| 7 | An evidence-based appraisal of reflux disease management — the Genval Workshop Reportbreakdown → | 681 |
| 8 | 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease. | 53 |
| 9 | 68 | |
| 10 | 148 | |
| 11 | 101 | |
| 12 | 1 | |
| 13 | 16 | |
| 14 | 39 | |
| 15 | 36 | |
| 16 | 75 | |
| 17 | 42 | |
| 18 | 39 | |
| 19 | 1 | |
| 20 | 13 |
About K. Lauritsen
K. Lauritsen is a scholar working on Gastroenterology, Surgery and Pharmacology, having authored 108 papers that have together received 5.3k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (59 papers), Gastroesophageal reflux and treatments (40 papers) and Eosinophilic Esophagitis (26 papers). The work is most often cited by research in Gastroenterology (3.0k citations), Surgery (3.7k citations) and Genetics (1.1k citations). K. Lauritsen has collaborated with scholars based in Denmark, Sweden and Australia. Frequent co-authors include J Rask-Madsen, Klaus Bukhave, Nicholas J. Talley, L. Laursen, Laurits S. Laursen, Troels Havelund, Ola Junghard, Tore Lind, A. Mark Fendrick and E. Bolling‐Sternevald. Their work appears in journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.